Korean Drug Co. Ltd (014570) — Financial Flexibility Index
Korean Drug Co. Ltd (014570) has a Financial Flexibility Index of 0.27x as of September 2025. Free cash flow of ₩3.79 Billion (operating CF ₩3.72 Billion minus capex ₩67.38 Million) represents 0% of total liabilities (₩14.01 Billion). Also explore net asset momentum of Korean Drug Co. Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Korean Drug Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Korean Drug Co. Ltd across 11 annual periods. Check 014570 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Korean Drug Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Korean Drug Co. Ltd. For the full company profile including market capitalisation, see 014570 company net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | ₩5.91 Billion | ₩4.87 Billion | ₩10.78 Billion | ▲ +75.8% |
| 2023 | 0.31x | ₩3.94 Billion | ₩-2.00 Billion | ₩12.62 Billion | ▼ -74.5% |
| 2022 | 1.22x | ₩12.01 Billion | ₩5.91 Billion | ₩9.80 Billion | ▲ +46.7% |
| 2021 | 0.83x | ₩9.95 Billion | ₩8.81 Billion | ₩11.92 Billion | ▼ -20.3% |
| 2020 | 1.05x | ₩13.07 Billion | ₩12.33 Billion | ₩12.47 Billion | ▲ +22.2% |
| 2019 | 0.86x | ₩9.26 Billion | ₩6.21 Billion | ₩10.80 Billion | ▲ +22.9% |
| 2018 | 0.70x | ₩7.09 Billion | ₩5.79 Billion | ₩10.16 Billion | ▲ +333.7% |
| 2017 | 0.16x | ₩1.58 Billion | ₩447.20 Million | ₩9.82 Billion | ▼ -64.6% |
| 2016 | 0.45x | ₩4.42 Billion | ₩3.96 Billion | ₩9.75 Billion | ▼ -38.4% |
| 2015 | 0.74x | ₩7.01 Billion | ₩6.13 Billion | ₩9.52 Billion | ▲ +97.1% |
| 2014 | 0.37x | ₩5.00 Billion | ₩4.46 Billion | ₩13.38 Billion | — |